Total Synthesis of a 6,6-Spiroketal Metabolite, Dinemasone A
1.89 (m, 1 H), 1.83–1.74 (m, 1 H), 1.60–1.54 (m, 2 H), 1.27 (d, J 3 H), 1.12 (d, J = 6.2 Hz, 3 H) ppm. 13C NMR (75 MHz, CDCl3):
= 6.0 Hz, 3 H), 1.10 (d, J = 6.0 Hz, 3 H), 0.87 (s, 18 H), 0.06 (d, J
= 2.0 Hz, 6 H), 0.03 (s, 3 H), 0.02 (s, 3 H) ppm. 13C NMR
(75 MHz, CDCl3): δ = 188.1, 137.3, 128.3, 128.0, 127.9, 93.6, 89.1,
83.9, 72.8, 70.9, 69.4, 68.4, 67.9, 34.8, 31.2, 25.8, 25.7, 23.7, 20.1,
18.0, 17.9, –4.31, –4.36, –4.7, –4.8 ppm. MS (ESI): m/z = 661 [M
+ Na]+. HRMS-ESI: calcd. for C37H59O5Si2 [M + H]+ 639.3896;
found 639.3892.
δ = 206.0, 137.9, 137.2, 128.3, 127.9, 127.6, 100.2, 82.4, 73.3, 72.1,
71.0, 67.1, 60.3, 47.3, 26.1, 21.6, 21.4, 19.6 ppm. MS (ESI): m/z =
411 [M + H]+. HRMS-ESI: calcd. for C25H31O5 [M + H]+
411.2166; found 411.2160.
(2S,3S,6S,8R,11S)-3,11-Dihydroxy-2,8-dimethyl-1,7-dioxaspiro-
[5.5]undecan-4-one (1)
Method A, Hydrogenation of 22: Palladium on carbon (10% by
weight, 12 mg) was added to a solution of compound 22 (16 mg,
0.04 mmol) in EtOAc (3 mL). The reaction mixture was stirred
overnight under a hydrogen atmosphere. After completion of the
reaction, the mixture was filtered through Celite, and the filtrate
was concentrated in vacuo. Column chromatography of the residue
on silica gel (40 % ethyl acetate in hexanes) gave compound 1
(8.5 mg, 95%) as a white solid. M.p. 147–149 °C (ref.[3] 149 °C).
(2S,3S,7S,10R)-3,7-Bis(benzyloxy)-2,10-dihydroxyundec-5-yn-4-one
(21): Aqueous HF (25%, 1 mL) was added to a stirred solution of
compound 4 (120 mg, 0.18 mmol) in acetonitrile (20 mL) at room
temperature, and the mixture was stirred for 5 h. The reaction was
quenched with saturated aqueous NaHCO3 (15 mL). The phases
were separated, and the aqueous phase was extracted with ethyl
acetate (3ϫ 10 mL). The combined organic extracts were washed
with brine (10 mL), dried with Na2SO4, and concentrated in vacuo.
The residue was purified by column chromatography (30% ethyl
acetate in hexanes) to give compound 21 (68 mg, 88%) as a colour-
[α]2D0 = –79.3 (c = 0.21, CHCl ). IR (neat): ν = 3485, 3422, 3380,
˜
3
2920, 2853, 1722, 1381, 1334, 1278, 1220, 1165, 1134, 1073, 993,
929, 772 cm–1. 1H NMR (700 MHz, CDCl3): δ = 4.06 (dq, J = 9.5,
6.1 Hz, 1 H), 3.89 (sext, J = 6.1 Hz, 1 H), 3.83 (dd, J = 9.5, 1.0 Hz,
1 H) 3.55 (m, 1 H), 3.52 (d, J = 4.0 Hz, 1 H), 2.90 (d, J = 13.8 Hz,
1 H), 2.83 (dd, J = 13.8, 1.0 Hz, 1 H), 2.50 (d, J = 6.3 Hz, 1 H),
1.98 (m, 1 H), 1.75 (m, 1 H), 1.66 (m, 2 H), 1.46 (d, J = 6.1 Hz, 3
H), 1.26 (d, J = 6.1 Hz, 3 H) ppm. 13C NMR (175 MHz, CDCl3):
δ = 205.9, 101.3, 77.9, 72.5, 69.9, 69.6, 44.9, 27.5, 24.7, 20.7,
18.7 ppm. MS (ESI): m/z = 253 [M + Na]+. HRMS-ESI: calcd. for
C11H18O5Na [M + Na]+ 253.1046; found 253.1045.
less liquid. [α]2D0 = –117.6 (c = 0.5, CHCl ). IR (neat): ν = 3410,
˜
3
2967, 2921, 2871, 2208, 1671, 1453, 1261, 1218, 1084, 772,
1
699 cm–1. H NMR (300 MHz, CDCl3): δ = 7.40–7.25 (m, 10 H),
4.81 (d, J = 12.0 Hz, 1 H), 4.77 (d, J = 12.0 Hz, 1 H), 4.49 (dd, J
= 4.1, 11.5 Hz, 2 H), 4.30 (t, J = 6.2 Hz, 1 H), 4.23–4.15 (m, 1 H),
3.92 (d, J = 4.7 Hz, 1 H), 3.82–3.70 (m, 1 H), 2.03–1.77 (m, 2 H),
1.71–1.48 (m, 2 H), 1.26 (d, J = 6.2 Hz, 3 H), 1.15 (d, J = 6.2 Hz,
3 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 187.6, 136.9, 136.8,
128.5, 128.1, 128.0, 94.4, 83.3, 84.0, 73.1, 71.2, 68.3, 67.3, 60.3,
34.4, 31.1, 23.4, 18.3 ppm. MS (ESI): m/z = 433 [M + Na]+.
HRMS-ESI: calcd. for C25H31O5 [M + H]+ 411.2166; found
411.2162.
Method B, Spiroepimerisation of 1a: Anhydrous ZnBr2 (14.6 mg,
0.06 mmol) was added to a stirred solution of 1a (15.0 mg,
0.06 mmol) in CH2Cl2 (2 mL) at room temperature. After 5 h, the
reaction was quenched with saturated aqueous NaHCO3 (3 mL),
and the mixture was extracted with EtOAc. The organic extract
was washed with brine (3 mL), dried with Na2SO4, filtered, and
concentrated in vacuo. The residue was purified by column
chromatography over silica gel (30% EtOAc in hexanes) to give
dinemasone A (1, 9.5 mg, 63%) as a white solid, together with reco-
vered 1a (4.0 mg, 27%). These isolated products were fully charac-
terised and gave data comparable with that obtained above.
(2S,3S,6S,8R,11S)-3,11-Bis(benzyloxy)-2,8-dimethyl-1,7-dioxaspiro-
[5.5]undecan-4-one (22) and (2S,3S,6R,8R,11S)-3,11-Bis(benz-
yloxy)-2,8-dimethyl-1,7-dioxaspiro[5.5]undecan-4-one (22a): p-Tolu-
enesulfonic acid monohydrate (48 mg, 0.25 mmol) was added to a
stirred solution of ynone 21 (70 mg, 0.17 mmol) in toluene (2 mL).
The mixture was stirred for 12 h. Then the reaction was quenched
with saturated aqueous NaHCO3 (2 mL), and the phases were sep-
arated. The aqueous phase was extracted with ethyl acetate (2ϫ
5 mL). The combined organic extracts were washed with brine
(5 mL), dried with Na2SO4 and concentrated in vacuo. The residue
was purified by column chromatography (5% ethyl acetate in hex-
anes) to give compound 22 (19 mg) as a colourless solid, and 22a
(43 mg) as a colourless syrup (combined yield 89%).
(2S,3S,6R,8R,11S)-3,11-Dihydroxy-2,8-dimethyl-1,7-dioxaspiro-
[5.5]undecan-4-one (6-epi-dinemasone A, 1a): By the same protocol
as that described for the preparation of 1, 22a (40 mg, 0.1 mmol)
was converted into 1a (21 mg, 93%) as a colourless liquid. [α]D20
=
+64.4 (c = 0.5, CHCl ). IR (neat): ν = 3434, 2931, 1727, 1448,
˜
3
1071, 1010, 968, 757 cm–1. 1H NMR (300 MHz, CDCl3): δ = 4.28–
4.18 (m, 1 H), 4.15 (dd, J = 1.5, 9.8 Hz, 1 H), 3.67–3.56 (m, 2 H),
3.47 (d, J = 3.7 Hz, 1 H), 3.05 (d, J = 15.8 Hz, 1 H), 2.74 (dd, J =
1.5, 15.8 Hz, 1 H), 2.17–2.00 (m, 2 H), 1.80–1.68 (m, 2 H), 1.47 (d,
J = 6.0 Hz, 3 H), 1.18 (d, J = 6.0 Hz, 3 H) ppm. 13C NMR
(75 MHz, CDCl3): δ = 207.1, 100.1, 76.7, 73.1, 66.9, 65.3, 45.8,
25.7, 25.4, 21.5, 19.7 ppm. MS (ESI): m/z = 253 [M + Na]+.
HRMS-ESI: calcd. for C11H18O5Na [M + Na]+ 253.1046; found
253.1045.
Data for 22: [α]2D0 = –140.2 (c = 0.8, CHCl ). IR (neat): ν = 2925,
˜
3
1731, 1451, 1218, 1118, 1075, 1012, 772, 698 cm–1
.
1H NMR
(300 MHz, CDCl3): δ = 7.39–7.27 (m, 10 H), 4.94 (d, J = 11.9 Hz,
1 H), 4.73 (d, J = 11.9 Hz, 1 H), 4.61 (d, J = 11.9 Hz, 1 H), 4.50
(d, J = 10.9 Hz, 1 H), 4.28 (qd, J = 6.0, 9.0 Hz, 1 H), 3.91 (sext, J
= 6.0 Hz, 1 H), 3.66 (dd, J = 1.0, 9.0 Hz, 1 H), 3.26 (dd, J = 4.0,
8.0 Hz, 1 H), 2.82 (dd, J = 1.0, 13.0 Hz, 1 H), 2.52 (d, J = 14.0 Hz,
1 H), 1.96 (m, 1 H), 1.77 (m, 1 H), 1.68 (m, 2 H), 1.41 (d, J =
6.0 Hz, 3 H), 1.25 (d, J = 6.0 Hz, 3 H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 204.8, 138.1, 137.5, 128.4, 128.2, 128.0, 127.9, 127.8,
101.5, 84.0, 76.1, 73.1, 71.6, 70.4, 69.5, 47.8, 29.6, 28.4, 21.4, 20.7,
18.6 ppm. MS (ESI): m/z = 411 [M + H]+.
Supporting Information (see footnote on the first page of this arti-
cle): Copies of the 1H and 13C NMR of all compounds, and
NOESY, COSY, and HSQC analysis of the target molecule.
Data for 22a: [α]2D0 = –23.0 (c = 1.0, CHCl ). IR (neat): ν = 2927,
˜
3
1732, 1452, 1216, 1118, 1076, 1013, 771, 698 cm–1
.
1H NMR
Acknowledgments
(300 MHz, CDCl3): δ = 7.37–7.24 (m, 10 H), 4.91 (d, J = 11.3 Hz,
1 H), 4.59 (d, J = 11.7 Hz, 1 H), 4.51 (d, J = 11.3 Hz, 1 H), 4.42
B. S., U. D., and K. V. M. R. thank Council of Scientific and Indus-
(d, J = 11.7 Hz, 1 H), 4.12–4.03 (m, 1 H), 3.93–3.85 (m, 2 H), 3.34 trial Research (CSIR), New Delhi, for research fellowships. The
(t, J = 3.0 Hz, 1 H), 2.88 (d, J = 15.6 Hz, 1 H), 2.76 (d, J = 15.6 Hz, authors are grateful to the reviewers of this article for their sugges-
1 H), 1.90–1.80 (m, 2 H), 1.70–1.52 (m, 2 H), 1.34 (d, J = 5.6 Hz, tions in improving the quality of the manuscript.
Eur. J. Org. Chem. 2013, 525–532
© 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
531